Consideraçöes sobre lipoproteínas, risco cardiovascular e conotaçäo com o ciclo gravídico-puerperal

Martinez, Tânia Leme da Rocha; Paiva, Therezinha Bandiera; Auriemo, Caio Roberto Chimenti; Piageti, Ana Luiza Araújo; Delascio, Domingos; Camano, Luiz; Bertini Oliveira, Anna Maria; Martinez Filho, Eulógio Emílio.
Folha méd ; 91(1): 11-5, jul. 1985.
Artículo en Portugués | LILACS | ID: lil-30607

Documentos relacionados

  1. [Lipoproteins (A) after a history of myocardial infarction, arteriosclerosis obliterans, hypertension and hyperlipidemia].
  2. [Microangiopathy in preeclampsia: the usefulness of the peripheral blood smear].
  3. Novel lipoprotein density profiling in healthy dogs of various breeds, healthy Miniature Schnauzers, and Miniature Schnauzers with hyperlipidemia.
  4. Exercise and Hyperlipidemia.
  5. Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease.
  6. [Hyperlipidemia and atherosclerosis in Switzerland. Results from the "Basler studie" (author's transl)].
  7. [Plasma lipids in normal subjects, and in patients with coronary disease and peripheral arteriopathy].
  8. Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?
  9. Maternal gestational diabetes and childhood hyperlipidemia.
  10. Correlation between plasma proprotein convertase subtilisin/kexin type 9 and blood lipids in patients with newly diagnosed primary nephrotic syndrome.